You are here

  • Home
  • Online First
  • Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab due to side effects

Article Text

Article menu

See original article:

other Versions

Download PDFPDF
Concise Report
Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab due to side effects

http://dx.doi.org/10.1136/ard.2006.058776

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    PDF extract preview

    This is a PDF-only article. The first page of the PDF of this article appears above.

    Linked Articles

    • Correction
      CORRECTION
      BMJ Publishing Group Ltd and European League Against Rheumatism
      Annals of the Rheumatic Diseases 2007; 66 847-847 Published Online First: 18 May 2007. doi: 10.1136/ard.2006.058776.corr1